NURECA
|
NURECA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1.34 Cr | ₹-2.54 Cr | ₹-11 Cr | ₹61 Cr | ₹62 Cr |
| Adjustment | ₹-8.59 Cr | ₹-6.76 Cr | ₹-3.48 Cr | ₹-3.73 Cr | ₹0.11 Cr |
| Changes In working Capital | ₹-10 Cr | ₹5.34 Cr | ₹29 Cr | ₹-38 Cr | ₹-13 Cr |
| Cash Flow after changes in Working Capital | ₹-18 Cr | ₹-3.96 Cr | ₹14 Cr | ₹19 Cr | ₹50 Cr |
| Cash Flow from Operating Activities | ₹-19 Cr | ₹-2.71 Cr | ₹10 Cr | ₹1.40 Cr | ₹35 Cr |
| Cash Flow from Investing Activities | ₹8.44 Cr | ₹18 Cr | ₹-16 Cr | ₹-3.09 Cr | ₹-110 Cr |
| Cash Flow from Financing Activities | ₹-0.17 Cr | ₹-1.30 Cr | ₹-1.51 Cr | ₹-7.30 Cr | ₹92 Cr |
| Net Cash Inflow / Outflow | ₹-11 Cr | ₹14 Cr | ₹-7.74 Cr | ₹-8.99 Cr | ₹17 Cr |
| Opening Cash & Cash Equivalents | ₹14 Cr | ₹0.50 Cr | ₹8.25 Cr | ₹17 Cr | ₹0.07 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹-0.01 Cr | ₹0.00 Cr | ₹-0.01 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Closing Cash & Cash Equivalent | ₹3.24 Cr | ₹14 Cr | ₹0.50 Cr | ₹8.25 Cr | ₹17 Cr |
Compare Cashflow Statement of peers of NURECA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NURECA | ₹312.0 Cr | -7.3% | 34.1% | 2.6% | Stock Analytics | |
| POLY MEDICURE | ₹19,277.6 Cr | 1.2% | -4% | -23.8% | Stock Analytics | |
NURECA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | -7.3% |
34.1% |
2.6% |
| SENSEX | 1% |
3.3% |
4.5% |
You may also like the below Video Courses